Matches in Wikidata for { <http://www.wikidata.org/entity/Q106965971> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q106965971 description "clinical trial" @default.
- Q106965971 description "ensayo clínico" @default.
- Q106965971 description "ensayu clínicu" @default.
- Q106965971 description "klinisch onderzoek" @default.
- Q106965971 description "клінічне випробування" @default.
- Q106965971 description "կլինիկական փորձարկում" @default.
- Q106965971 description "临床试验" @default.
- Q106965971 name "An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD" @default.
- Q106965971 name "An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD" @default.
- Q106965971 type Item @default.
- Q106965971 label "An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD" @default.
- Q106965971 label "An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD" @default.
- Q106965971 prefLabel "An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD" @default.
- Q106965971 prefLabel "An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD" @default.
- Q106965971 P1050 Q106965971-38BE80D4-CE0F-4A77-A529-22450631D875 @default.
- Q106965971 P1050 Q106965971-EBF5B6BD-4533-494A-ADED-F0ABF4454A0C @default.
- Q106965971 P1132 Q106965971-B82950A1-1004-4FDB-BB91-F05F3DE649CE @default.
- Q106965971 P1476 Q106965971-8307CC0B-0343-47A9-8543-54CD9790FFE5 @default.
- Q106965971 P17 Q106965971-A7571D87-FD73-4EC7-BDAF-D6B1663E7D59 @default.
- Q106965971 P1813 Q106965971-84598420-27AF-4F3F-9BC1-4AA5453F3E2B @default.
- Q106965971 P2899 Q106965971-EC8E9DF8-6620-4197-8D65-132AF3913AC2 @default.
- Q106965971 P3098 Q106965971-DD107AE0-DA5C-4C85-9454-5F295A99C4DF @default.
- Q106965971 P31 Q106965971-E4E58264-076C-4F36-B51B-7CD3DA507E01 @default.
- Q106965971 P580 Q106965971-5A9E8935-B210-46DB-9688-D5345A62742D @default.
- Q106965971 P582 Q106965971-0C0392B0-CA26-48D3-B0E1-05F96AA1A835 @default.
- Q106965971 P6099 Q106965971-F490BF0D-E6A7-42DB-AFDF-7BF453932601 @default.
- Q106965971 P6153 Q106965971-129D7303-CF4B-4420-AF43-4BABA4FD385E @default.
- Q106965971 P6153 Q106965971-14719630-BC67-4781-91B4-EFB362684F8A @default.
- Q106965971 P6153 Q106965971-C31FF894-BEFA-4715-8136-CC34E15BBD4F @default.
- Q106965971 P6153 Q106965971-F721EBC3-774C-402E-AB4D-43BE670F6E7A @default.
- Q106965971 P8005 Q106965971-CABF3DAA-AC7A-4F12-9FC5-15380CED6A6D @default.
- Q106965971 P8363 Q106965971-1A5DE1DD-E8E2-41A8-AE09-3FFC1F7CD301 @default.
- Q106965971 P1050 Q194520 @default.
- Q106965971 P1050 Q27429789 @default.
- Q106965971 P1132 "+1200" @default.
- Q106965971 P1476 "A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration" @default.
- Q106965971 P17 Q30 @default.
- Q106965971 P1813 "GALE" @default.
- Q106965971 P2899 "+60" @default.
- Q106965971 P3098 "NCT04770545" @default.
- Q106965971 P31 Q30612 @default.
- Q106965971 P580 "2021-03-04T00:00:00Z" @default.
- Q106965971 P582 "2025-07-01T00:00:00Z" @default.
- Q106965971 P6099 Q42824827 @default.
- Q106965971 P6153 Q30269573 @default.
- Q106965971 P6153 Q30270222 @default.
- Q106965971 P6153 Q30270224 @default.
- Q106965971 P6153 Q30296372 @default.
- Q106965971 P8005 Q92331923 @default.
- Q106965971 P8363 Q78089383 @default.